Emgality is a prescription medication used for the preventive treatment of migraine in adults and for the treatment of episodic cluster headaches. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) antagonists. Emgality is administered through subcutaneous injection and works by targeting and blocking the activity of CGRP, a molecule involved in migraine attacks and cluster headaches. By inhibiting the action of CGRP, Emgality can help reduce the frequency of migraine days and the severity of cluster headaches, improving the quality of life for individuals suffering from these conditions. It is typically prescribed when other treatments have failed or are not suitable for the patient.
When using Emgality, a medication primarily prescribed for the prevention of migraine headaches and the treatment of cluster headaches, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. Due to potential side effects, such as dizziness or fatigue, patients should exercise caution when driving or operating heavy machinery until they are certain of how Emgality affects them. Common side effects include injection site reactions (pain, redness, or itching), constipation, and muscle spasms. While rare, more serious side effects can occur, and any unusual symptoms should be reported to your doctor immediately. It's also essential to inform your healthcare provider about all other medications you are taking, as Emgality can interact with other drugs, potentially altering its effectiveness or increasing side effects. Always prioritize safety and open communication with your healthcare provider when using Emgality.